{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:32:24Z","timestamp":1786116744311,"version":"build-2736575974"},"reference-count":99,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clp.2026.04.006","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T19:48:19Z","timestamp":1782503299000},"page":"481-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacologic Treatment of Diabetes in Pregnancy"],"prefix":"10.1016","volume":"53","author":[{"given":"Maisa N.","family":"Feghali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clp.2026.04.006_bib1","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1097\/AOG.0000000000002960","article-title":"ACOG practice bulletin no. 201: pregestational diabetes mellitus","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.clp.2026.04.006_bib2","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/AOG.0000000000002501","article-title":"ACOG practice bulletin no. 190: gestational diabetes mellitus","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"Supplement_1","key":"10.1016\/j.clp.2026.04.006_bib3","first-page":"S306","article-title":"15. Management of diabetes in pregnancy: standards of care in Diabetes\u20142025","volume":"48","year":"2024","journal-title":"Diabetes Care"},{"issue":"Supplement_1","key":"10.1016\/j.clp.2026.04.006_bib4","first-page":"S27","article-title":"2. Diagnosis and classification of diabetes: standards of care in Diabetes\u20142025","volume":"48","year":"2024","journal-title":"Diabetes Care"},{"issue":"43","key":"10.1016\/j.clp.2026.04.006_bib5","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.15585\/mmwr.mm6743a2","article-title":"Prevalence and changes in preexisting diabetes and gestational diabetes among women who had a live birth - united States, 2012-2016","volume":"67","author":"Deputy","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.clp.2026.04.006_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12884-024-06378-2","article-title":"Prevalence of gestational diabetes in the United States and Canada: a systematic review and meta-analysis","volume":"24","author":"Eades","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"issue":"8","key":"10.1016\/j.clp.2026.04.006_bib7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jcjd.2023.07.007","article-title":"Temporal trends in type 1, type 2, and gestational diabetes in pregnancy: impact of rural residence, ethnicity, and material deprivation","volume":"47","author":"Ngwezi","year":"2023","journal-title":"Can J Diabetes"},{"issue":"10448","key":"10.1016\/j.clp.2026.04.006_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(24)00825-0","article-title":"Epidemiology and management of gestational diabetes","volume":"404","author":"Sweeting","year":"2024","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.clp.2026.04.006_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11892-018-1093-2","article-title":"Oral agents for the treatment of gestational diabetes","volume":"18","author":"Finneran","year":"2018","journal-title":"Curr Diab Rep"},{"issue":"6 Pt 1","key":"10.1016\/j.clp.2026.04.006_bib10","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/0002-9378(91)90012-G","article-title":"Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women","volume":"165","author":"Catalano","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"1 Pt 1","key":"10.1016\/j.clp.2026.04.006_bib11","first-page":"E60","article-title":"Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes","volume":"264","author":"Catalano","year":"1993","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.clp.2026.04.006_bib12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00125-009-1633-z","article-title":"Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction","volume":"53","author":"Garcia-Patterson","year":"2010","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.clp.2026.04.006_bib13","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.2337\/dc14-0506","article-title":"Falling insulin requirements are associated with adverse obstetric outcomes in women with preexisting diabetes","volume":"37","author":"Padmanabhan","year":"2014","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.clp.2026.04.006_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2337\/diacare.21.3.403","article-title":"Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance","volume":"21","author":"Catalano","year":"1998","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.clp.2026.04.006_bib15","doi-asserted-by":"crossref","first-page":"324.e1-e5","DOI":"10.1016\/j.ajog.2012.06.029","article-title":"Insulin pump dosing across gestation in women with well-controlled type 1 diabetes mellitus","volume":"207","author":"Roeder","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.clp.2026.04.006_bib16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0002-9378(99)70662-9","article-title":"Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus","volume":"180","author":"Catalano","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.clp.2026.04.006_bib17","first-page":"295","article-title":"A story of two miracles: the impact of the discovery of insulin on pregnancy in women with diabetes mellitus","volume":"79","author":"Gabbe","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"23","key":"10.1016\/j.clp.2026.04.006_bib18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJM191512021732302","article-title":"Pregnancy and diabetes mellitus","volume":"173","author":"Joslin","year":"1915","journal-title":"Boston Med Surg J"},{"key":"10.1016\/j.clp.2026.04.006_bib19","series-title":"The principles and practice of obstetrics","first-page":"502","year":"1913"},{"key":"10.1016\/j.clp.2026.04.006_bib20","series-title":"The treatment of diabetes mellitus","first-page":"870","article-title":"Diabetes in pregnancy","author":"White","year":"1928"},{"key":"10.1016\/j.clp.2026.04.006_bib21","series-title":"Diabetes in childhood and adolescence","first-page":"224","author":"White","year":"1932"},{"issue":"3","key":"10.1016\/j.clp.2026.04.006_bib22","first-page":"377","article-title":"Diabetes mellitus and pregnancy","volume":"21","author":"Walker","year":"1928","journal-title":"Proc R Soc Med"},{"issue":"5","key":"10.1016\/j.clp.2026.04.006_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0002-9343(49)90382-4","article-title":"Pregnancy complicating diabetes","volume":"7","author":"White","year":"1949","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.clp.2026.04.006_bib24","first-page":"253","article-title":"Insulin requirements during pregnancy in women with type I diabetes","volume":"83","author":"Steel","year":"1994","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.clp.2026.04.006_bib25","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2337\/diacare.24.7.1130","article-title":"Declining insulin requirement in the late first trimester of diabetic pregnancy","volume":"24","author":"Jovanovic","year":"2001","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.clp.2026.04.006_bib26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/qjmed\/94.5.255","article-title":"Insulin lispro and regular insulin in pregnancy","volume":"94","author":"Bhattacharyya","year":"2001","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.clp.2026.04.006_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1056\/NEJMra040832","article-title":"Insulin analogues","volume":"352","author":"Hirsch","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clp.2026.04.006_bib28","doi-asserted-by":"crossref","first-page":"186.e1-e7","DOI":"10.1016\/j.ajog.2007.08.005","article-title":"Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects","volume":"198","author":"Hod","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.clp.2026.04.006_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/dc06-1887","article-title":"Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women","volume":"30","author":"Mathiesen","year":"2007","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.clp.2026.04.006_bib30","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/dc11-2264","article-title":"Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes","volume":"35","author":"Mathiesen","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clp.2026.04.006_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/649070","article-title":"Meta-analysis of maternal and neonatal outcomes associated with the use of insulin glargine versus NPH insulin during pregnancy","volume":"2012","author":"Lepercq","year":"2012","journal-title":"Obstet Gynecol Int"},{"issue":"11","key":"10.1016\/j.clp.2026.04.006_bib32","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta14110","article-title":"Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation","volume":"14","author":"Cummins","year":"2010","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1016\/j.clp.2026.04.006_bib33","first-page":"CD005542","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes","volume":"2016","author":"Farrar","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.clp.2026.04.006_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ajog.2007.03.062","article-title":"Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials","volume":"197","author":"Mukhopadhyay","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.clp.2026.04.006_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/jwh.2014.4939","article-title":"Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: a systematic review and meta-analysis","volume":"24","author":"Ranasinghe","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"issue":"5","key":"10.1016\/j.clp.2026.04.006_bib36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.diabet.2011.02.002","article-title":"Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI)","volume":"37","author":"Bruttomesso","year":"2011","journal-title":"Diabetes Metab"},{"issue":"4","key":"10.1016\/j.clp.2026.04.006_bib37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/dia.2009.0140","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes","volume":"12","author":"Gonzalez-Romero","year":"2010","journal-title":"Diabetes Technol Ther"},{"issue":"10110","key":"10.1016\/j.clp.2026.04.006_bib38","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.clp.2026.04.006_bib39","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1602494","article-title":"Closed-loop insulin delivery during pregnancy in women with type 1 diabetes","volume":"375","author":"Stewart","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.clp.2026.04.006_bib40","first-page":"CD009613","article-title":"Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes","volume":"6","author":"Moy","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.clp.2026.04.006_bib41","first-page":"CD011880","article-title":"Different insulin types and regimens for pregnant women with pre-existing diabetes","volume":"2","author":"O'Neill","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4 Pt 1","key":"10.1016\/j.clp.2026.04.006_bib42","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0002-9378(91)90421-M","article-title":"Insignificant transfer of glyburide occurs across the human placenta","volume":"165","author":"Elliott","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.clp.2026.04.006_bib43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0002-9378(94)90078-7","article-title":"Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer","volume":"171","author":"Elliott","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"16","key":"10.1016\/j.clp.2026.04.006_bib44","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","article-title":"A comparison of glyburide and insulin in women with gestational diabetes mellitus","volume":"343","author":"Langer","year":"2000","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.clp.2026.04.006_bib45","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/AOG.0000000000000285","article-title":"Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011","volume":"123","author":"Camelo Castillo","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.clp.2026.04.006_bib46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/clpt.2009.5","article-title":"Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice","volume":"85","author":"Hebert","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.clp.2026.04.006_bib47","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/AOG.0000000000000672","article-title":"Glyburide transport across the human placenta","volume":"125","author":"Schwartz","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.clp.2026.04.006_bib48","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jamapediatrics.2015.74","article-title":"Association of adverse pregnancy outcomes with glyburide vs insulin in women with gestational diabetes","volume":"169","author":"Camelo Castillo","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.clp.2026.04.006_bib49","first-page":"CD011967","article-title":"Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes","volume":"1","author":"Brown","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.clp.2026.04.006_bib50","doi-asserted-by":"crossref","first-page":"457.e1-e9","DOI":"10.1016\/j.ajog.2010.06.044","article-title":"Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis","volume":"203","author":"Dhulkotia","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.clp.2026.04.006_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109985","article-title":"Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta-analysis","volume":"9","author":"Poolsup","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clp.2026.04.006_bib52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.advms.2014.03.001","article-title":"The use of glyburide in the management of gestational diabetes mellitus: a meta-analysis","volume":"59","author":"Zeng","year":"2014","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.clp.2026.04.006_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h102","article-title":"Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis","volume":"350","author":"Balsells","year":"2015","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.clp.2026.04.006_bib54","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.jp.7211147","article-title":"Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus","volume":"24","author":"Chmait","year":"2004","journal-title":"J Perinatol"},{"issue":"6","key":"10.1016\/j.clp.2026.04.006_bib55","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/01.AOG.0000218704.28313.36","article-title":"Predictors of glyburide failure in the treatment of gestational diabetes","volume":"107","author":"Kahn","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.clp.2026.04.006_bib56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14767050310001650725","article-title":"Use of glyburide for the treatment of gestational diabetes: the San Antonio experience","volume":"15","author":"Conway","year":"2004","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"10.1016\/j.clp.2026.04.006_bib57","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2337\/dc16-2307","article-title":"Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus: a randomized controlled study","volume":"40","author":"Nachum","year":"2017","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.clp.2026.04.006_bib58","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2018.01.041","article-title":"Pharmacological treatment of gestational diabetes","volume":"218","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"Supplement_1","key":"10.1016\/j.clp.2026.04.006_bib59","first-page":"S181","article-title":"Pharmacologic approaches to glycemic treatment: standards of care in Diabetes\u20142025","volume":"48","year":"2024","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.clp.2026.04.006_bib60","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab"},{"issue":"9131","key":"10.1016\/j.clp.2026.04.006_bib61","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK prospective diabetes study (UKPDS) group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2026.04.006_bib62","year":"2015"},{"issue":"11","key":"10.1016\/j.clp.2026.04.006_bib63","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.metabol.2013.06.006","article-title":"Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review","volume":"62","author":"Lautatzis","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.clp.2026.04.006_bib64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.reprotox.2018.07.004","article-title":"Pregnancy outcome after first-trimester exposure to metformin: a prospective cohort study","volume":"81","author":"Scherneck","year":"2018","journal-title":"Reprod Toxicol"},{"issue":"19","key":"10.1016\/j.clp.2026.04.006_bib65","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin versus insulin for the treatment of gestational diabetes","volume":"358","author":"Rowan","year":"2008","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.clp.2026.04.006_bib66","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2023.19869","article-title":"Early metformin in gestational diabetes: a randomized clinical trial","volume":"330","author":"Dunne","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clp.2026.04.006_bib67","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.dsx.2018.01.003","article-title":"Predictors of metformin failure in gestational diabetes mellitus (GDM)","volume":"12","author":"Khin","year":"2018","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"10.1016\/j.clp.2026.04.006_bib68","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/dmd.109.031245","article-title":"Pharmacokinetics of metformin during pregnancy","volume":"38","author":"Eyal","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.clp.2026.04.006_bib69","doi-asserted-by":"crossref","first-page":"e0191258","DOI":"10.1371\/journal.pone.0191258","article-title":"A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: an open-label, parallel group, randomized clinical study","volume":"13","author":"Chung","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clp.2026.04.006_bib70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/dme.13150","article-title":"Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis","volume":"34","author":"Butalia","year":"2017","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.clp.2026.04.006_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015557","article-title":"Treatments for gestational diabetes: a systematic review and meta-analysis","volume":"7","author":"Farrar","year":"2017","journal-title":"BMJ Open"},{"issue":"22","key":"10.1016\/j.clp.2026.04.006_bib72","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1001\/jama.2023.22949","article-title":"Metformin plus insulin for preexisting diabetes or gestational diabetes in early pregnancy: the MOMPOD randomized clinical trial","volume":"330","author":"Boggess","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clp.2026.04.006_bib73","doi-asserted-by":"crossref","first-page":"356.e1","DOI":"10.1016\/j.ajog.2015.12.019","article-title":"Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction","volume":"214","author":"Brownfoot","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.clp.2026.04.006_bib74","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1509819","article-title":"Metformin versus placebo in Obese pregnant women without diabetes mellitus","volume":"374","author":"Syngelaki","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clp.2026.04.006_bib75","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/dme.13523","article-title":"Risk of pre-eclampsia in women taking metformin: a systematic review and meta-analysis","volume":"35","author":"Alqudah","year":"2018","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.clp.2026.04.006_bib76","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cmet.2016.12.009","article-title":"Metformin inhibits hepatic mTORC1 signaling via dose-dependent mechanisms involving AMPK and the TSC complex","volume":"25","author":"Howell","year":"2017","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/j.clp.2026.04.006_bib77","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.clp.2026.04.006_bib78","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1463-1326.2003.00241.x","article-title":"Measurement of metformin concentration in erythrocytes: clinical implications","volume":"5","author":"Lalau","year":"2003","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.clp.2026.04.006_bib79","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.fertnstert.2004.11.051","article-title":"Placental passage of metformin in women with polycystic ovary syndrome","volume":"83","author":"Vanky","year":"2005","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.clp.2026.04.006_bib80","doi-asserted-by":"crossref","first-page":"e1222","DOI":"10.1542\/peds.2012-0346","article-title":"Metformin\u2019s effect on first-year weight gain: a follow-up study","volume":"130","author":"Carlsen","year":"2012","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.clp.2026.04.006_bib81","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1210\/jc.2010-0853","article-title":"Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study","volume":"95","author":"Vanky","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.clp.2026.04.006_bib82","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1210\/jc.2017-02419","article-title":"Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs","volume":"103","author":"Hanem","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.clp.2026.04.006_bib83","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2337\/dc11-0660","article-title":"Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age","volume":"34","author":"Rowan","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.clp.2026.04.006_bib84","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2017-000456","article-title":"Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age","volume":"6","author":"Rowan","year":"2018","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"5","key":"10.1016\/j.clp.2026.04.006_bib85","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s13300-018-0479-0","article-title":"Long-term effects of oral antidiabetic drugs during pregnancy on offspring: a systematic review and meta-analysis of Follow-up studies of RCTs","volume":"9","author":"van Weelden","year":"2018","journal-title":"Diabetes Ther"},{"issue":"3","key":"10.1016\/j.clp.2026.04.006_bib86","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20140620","article-title":"Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria","volume":"462","author":"Bridges","year":"2014","journal-title":"Biochem J"},{"issue":"12","key":"10.1016\/j.clp.2026.04.006_bib87","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/bjc.2016.385","article-title":"The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug","volume":"115","author":"Sacco","year":"2016","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.clp.2026.04.006_bib88","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.biochi.2013.05.011","article-title":"Potential role and therapeutic interests of myo-inositol in metabolic diseases","volume":"95","author":"Croze","year":"2013","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.clp.2026.04.006_bib89","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jnutbio.2012.01.008","article-title":"Chronic treatment with myo-inositol reduces white adipose tissue accretion and improves insulin sensitivity in female mice","volume":"24","author":"Croze","year":"2013","journal-title":"J Nutr Biochem"},{"issue":"2","key":"10.1016\/j.clp.2026.04.006_bib90","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/AOG.0000000000000958","article-title":"Myo-inositol supplementation for prevention of gestational diabetes in Obese pregnant women: a randomized controlled trial","volume":"126","author":"D'Anna","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.clp.2026.04.006_bib91","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3109\/09513590.2011.633665","article-title":"Myo-inositol may prevent gestational diabetes in PCOS women","volume":"28","author":"D'Anna","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"19","key":"10.1016\/j.clp.2026.04.006_bib92","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.3109\/14767058.2015.1121478","article-title":"Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial","volume":"29","author":"Santamaria","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"10.1016\/j.clp.2026.04.006_bib93","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2337\/dc16-2449","article-title":"The prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: a randomized controlled trial","volume":"40","author":"Farren","year":"2017","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.clp.2026.04.006_bib94","doi-asserted-by":"crossref","first-page":"300.e1","DOI":"10.1016\/j.ajog.2018.05.018","article-title":"Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs","volume":"219","author":"Santamaria","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.clp.2026.04.006_bib95","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1471-0528.1998.tb10234.x","article-title":"The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England","volume":"105","author":"Wilton","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.clp.2026.04.006_bib96","first-page":"42","article-title":"[Effectiveness of acarbose in the control of glucose tolerance worsening in pregnancy]","volume":"68","author":"Zarate","year":"2000","journal-title":"Ginecol Obstet Mex"},{"issue":"6","key":"10.1016\/j.clp.2026.04.006_bib97","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1515\/JPM.2005.092","article-title":"Perinatal outcomes and the use of oral hypoglycemic agents","volume":"33","author":"Bertini","year":"2005","journal-title":"J Perinat Med"},{"issue":"11","key":"10.1016\/j.clp.2026.04.006_bib98","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1007\/s00125-019-4961-7","article-title":"Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance","volume":"62","author":"Benhalima","year":"2019","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.clp.2026.04.006_bib99","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2337\/dc15-2672","article-title":"Heterogeneous contribution of insulin sensitivity and secretion defects to gestational diabetes mellitus","volume":"39","author":"Powe","year":"2016","journal-title":"Diabetes Care"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:13:15Z","timestamp":1786018395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510826000357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0095510826000357"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2026.04.006","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic Treatment of Diabetes in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2026.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}